Lighthouse Investment Partners’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Lighthouse Investment Partners’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20,746	Closed	-$121K	–	395
2022 Q4	$121K	Buy	+20,746	New	+$109K	0.01%	221

Lighthouse Investment Partners's CNCE Position: Q1 2023 in Review

Lighthouse Investment Partners sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 20,746 shares — an estimated $121K sold.

Lighthouse Investment Partners first reported a position in CNCE in Q4 2022 and held it in 1 quarter. The position peaked at $121K in Q4 2022. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.

Lighthouse Investment Partners reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Lighthouse Investment Partners sold 20,746 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $121K.
Lighthouse Investment Partners first reported a position in Concert Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
Lighthouse Investment Partners's Concert Pharmaceuticals, Inc. position peaked at $121K in Q4 2022.
0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.

Based on Lighthouse Investment Partners's 13F filing for Q1 2023, filed 15 May 2023.